Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: MAPP BIOPHARMACEUTICAL, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-09-19 to 2026-02-25
Current total value of award: $60500
Description: HUMAN-DERIVED MONOCLONAL ANTIBODIES AND RECOMBINANT ANTIGENS